Daniel Nixdorf

10PUBLICATIONS
59CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursAllergyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 01, 2026
TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome.

|Feb 24, 2026
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler

|Dec 04, 2025
TNF-α and IFN-γ differentially regulate AML cell susceptibility to CD70-antibody-mediated cytotoxicity.

Monika Sponheimer, Kieron White, Michelle Ulrich

|Dec 01, 2025
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler

|Feb 26, 2025
STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia.

Andreas Linder, Daniel Nixdorf, Niklas Kuhl

|Jan 11, 2024
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment.

Gerulf Hänel, Anne Schönle, Anne-Sophie Neumann

Pageof 2

Frequent Collaborators

7 joint publications

Nora Philipp

7 joint publications

Veit L Buecklein

6 joint publications

Maryam Kazerani

5 joint publications

Marion Subklewe